Monday 23rd May 2011
|Text too small?|
The New Zealand sharemarket started the week with a modest pull back from near three-year highs reached on Friday.
Around 10.20am the benchmark NZX-50 index was down 7.27 points to 3570.17, having topped 3578 on Friday and ending the day up 8.4 points.
In today's early trading, Fletcher Building (NZX: FBU ) lost 4c to $9.14, Freightways (NZX: FRE ) dropped 2c to $3.50, Skellerup (NZX: SKL ) was down 2c to $1.30, Contact Energy (NZX: CEN ) slipped 1c to $5.99, and Telecom (NZX: TEL ) was down 1c to 42.29.5.
In the US, shares ended last week with a fall, as euro zone debt issues continued to weigh on investors, and with retail stocks losing ground after a weak profit outlook from Gap.
"It seems like there's more of a consensus building that there's some potential risk coming on line here," said Natalie Trunow, chief investment officer of equities at Calvert Investment Management Inc in Bethesda, Maryland, which manages about US$14.8 billion.
"The economic recovery and macro picture do seem to indicate a more protracted slow economic recovery long term," Trunow said. "Unless we see a great deal of positive surprises on economic indicators, I think some of these negative events will continue to weigh on the market."
The Dow Jones industrial average ended down 0.7% at 12,512.04, the Standard & Poor's 500 Index was down 0.8% at 1333.27, and the Nasdaq Composite Index was down 0.7% to close at 2803.32.
For the week, the Dow was down 0.7%, the S&P 500 was down 0.3% and the Nasdaq was down 0.9%.
No comments yet
TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto
19th October 2021 Morning Report
PGG Wrightson Limited (NZX: PGW) Guidance Update
Vital Limited (NZX: VTL) Provides Update on PSN LMR
18th October 2021 Morning Report
T&G Global Limited (NZX: TGG) FY21 Earnings Guidance Update
Arvida Group Limited (NZX: ARV) Successful Completion of $155m Placement
FreshLeaf: Cannabis on course to be 'medicine of the masses'